Zobrazeno 1 - 10 of 17 pro vyhledávání: '"N. K. De Boer"'
1
Akademický článek
Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study
Autor: M. M. van de Meeberg, M. L. Seinen, H. H. Fidder, M. Lin, B. Oldenburg, N. K. de Boer, G. Bouma, R. de Jonge, M. Bulatović Ćalasan, the Dutch Initiative on Crohn and Colitis (ICC)
Publikováno v: BMC Gastroenterology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Methotrexate is an immunomodulatory drug for patients with Crohn’s disease. Erythrocyte MTX-polyglutamates (MTX-PG1-5) may be used for therapeutic drug monitoring (TDM) as MTX-PG is thought to mediate MTX’s efficacy. Informati
Externí odkaz: https://doaj.org/article/de092462ed2d4ae7b0cebbc7ba757245
Zobrazit plný text záznamu
2
P459 High inadequate surveillance rates in colitis-associated advanced neoplasia: a multicenter retrospective cohort study
Autor: M Te Groen, M E Derks, C P Peters, G Dijkstra, A C De Vries, T E Römkens, C S Horjus, N K De Boer, M E De Jong, I D Nagtegaal, L A Derikx, F Hoentjen
Publikováno v: Journal of Crohn's and Colitis. 16:i435-i436
Background Although colorectal cancer (CRC) surveillance is embedded in IBD practice, a subset of patients still develops advanced neoplasia (AN; high-grade dysplasia (HGD) and/or CRC). We aimed to determine the most plausible explanations for AN in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2991e20bf1a5da18c934dfab45b50b1b
https://doi.org/10.1093/ecco-jcc/jjab232.586
Zobrazit plný text záznamu
3
P288 Recurrence rates of advanced neoplasia after endoscopic or surgical resection in Inflammatory Bowel Disease patients: a retrospective cohort study
Autor: M Derks, M te Groen, C P Peters, G Dijkstra, A C de Vries, T E Römkens, C S Horjus, N K de Boer, I D Nagtegaal, L A Derikx, F Hoentjen
Publikováno v: Journal of Crohn's and Colitis. 16:i320-i321
Background Inflammatory bowel disease (IBD) patients are at increased risk of advanced neoplasia (AN) including high grade dysplasia (HGD) and colorectal cancer (CRC). Historically, a (sub)total colectomy was recommended in these patients, but altern
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b18b614b24270e82211e91243a9ebc2
https://doi.org/10.1093/ecco-jcc/jjab232.415
Zobrazit plný text záznamu
4
P284 Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn’s disease: a prospective study based on clinical risk stratification
Autor: J H Arkenbosch, E M J Beelen, G Dijkstra, M Romberg-Camps, M Duijvestein, F Hoentjen, S van der Marel, P W J Maljaars, S Jansen, N K de Boer, R West, C Horjus, L P S Stassen, F van Schaik, O van Ruler, B J H Jharap, N E Erler, M Doukas, A H A G Ooms, G Kats-Ugurlu, J van der Woude, A C De Vries
Publikováno v: Journal of Crohn's and Colitis. 16:i316-i317
Background In patients with Crohn’s disease (CD), postoperative prophylactic medication based on clinical risk stratification is recommended in international guidelines to prevent recurrence after ileocolonic resection (ICR). This study aimed to ev
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::97762df23a42a2564c6634b3e3dbb263
https://doi.org/10.1093/ecco-jcc/jjab232.411
Zobrazit plný text záznamu
5
Favourable tolerability and drug survival of tioguanine versus methotrexate after failure of conventional thiopurines in Crohn's disease
Autor: E H J Savelkoul, M H J Maas, A R Bourgonje, F Crouwel, V B C Biemans, N den Broeder, M G V M Russel, T E H Römkens, N K de Boer, G Dijkstra, F Hoentjen
Publikováno v: Savelkoul, E H J, Maas, M H J, Bourgonje, A R, Crouwel, F, Biemans, V B C, den Broeder, N, Russel, M G V M, Römkens, T E H, de Boer, N K, Dijkstra, G & Hoentjen, F 2022, ' Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease ', Journal of Crohn's & colitis, vol. 16, no. 9, pp. 1372-1379 . https://doi.org/10.1093/ecco-jcc/jjac044
Journal of Crohn's and Colitis, 16, 1372-1379
Journal of Crohn's and Colitis, 16(9). Oxford University Press
Journal of Crohn's & colitis, 16(9), 1372-1379. Elsevier
Journal of Crohn's and Colitis, 16, 9, pp. 1372-1379
Background and Aims Both methotrexate and tioguanine can be considered as treatment options in patients with Crohn’s disease after failure of conventional thiopurines. This study aimed to compare tolerability and drug survival of methotrexate and t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6344a2397e3b0875b3ca5bfe7b37bb52
https://research.rug.nl/en/publications/f55164fa-079e-4830-96de-0ef05580b51f
Zobrazit plný text záznamu
6
P592 Effectiveness and safety of thioguanine in thiopurine-naïve Inflammatory Bowel Disease patients
Autor: F Crouwel, A B Bayoumy, C J J Mulder, J H C Peters, P J Boekema, L J J Derijks, S Y De Boer, P C van de Meeberg, I Ahmad, H J C Buiter, N K de Boer
Publikováno v: Journal of Crohn's and Colitis. 16:i529-i529
Background Currently thioguanine is considered as off-label rescue therapy for Inflammatory Bowel Disease (IBD) after conventional thiopurine failure. This study aimed to determine the safety, effectiveness and 12-month drug tolerability of thioguani
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5c0df39e8340dbdfb1c07f6f67f0114
https://doi.org/10.1093/ecco-jcc/jjab232.718
Zobrazit plný text záznamu
7
P331 The safety of tioguanine exposure during pregnancy: a case series of seventy-three pregnancies
Autor: M A de Boer, H J C Buiter, Colitis (Icc), F Crouwel, M Simsek, Chris J. J. Mulder, N K De Boer
Publikováno v: Journal of Crohn's and Colitis. 15:S354-S355
Background Azathioprine and mercaptopurine exposure during conception and pregnancy has been considered safe in patients with inflammatory bowel disease (IBD). Its use is not associated with a higher risk of preterm birth or low birthweight. Data on
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c4b51de883e0dcc425c66153aa520bf6
https://doi.org/10.1093/ecco-jcc/jjab076.455
Zobrazit plný text záznamu
8
DOP79 Primary hypogammaglobulinemia with IBD-like features: An ECCO CONFER Multicenter Case Series
Autor: A Albshesh, P Eder, D G Ribaldone, B Oldenburg, N K De Boer, G J Mantzaris, E V Savarino, G Dragoni, R Weisshof, M Truyens, S Festa, M H Maillard, L Capirchio, R Filip, U Kopylov
Publikováno v: Journal of Crohn's and Colitis. 15:S111-S111
Background The most commonly recognized clinical feature of hypogammaglobulinemia is recurrent infections with high prevalence of gastrointestinal manifestations. In some cases, clinical and endoscopic features are indistinguishable from those of inf
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::639922d3e45d0758fcee01647b78cace
https://doi.org/10.1093/ecco-jcc/jjab073.118
Zobrazit plný text záznamu
9
P538 The reliability of patient performed fecal calprotectin testing
Autor: F Crouwel, L E J L Dijkhuis, H J C Buiter, H M Hamer, N K De Boer, M Duijvestein
Publikováno v: Journal of Crohn's and Colitis. 15:S510-S510
Background For measurement of fecal calprotectin (FC) a stool sample is sent to the laboratory, where calprotectin is extracted and determined. With the CALiaGold (CG) tube, especially designed for home sampling, this labor-intensive extraction proce
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bfa73c1b0b982b824a9e564426b4c1d5
https://doi.org/10.1093/ecco-jcc/jjab076.659
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje